Literature DB >> 24647220

A diagnostic and statistical manual of mental disorders history of premenstrual dysphoric disorder.

Peter Zachar1, Kenneth S Kendler.   

Abstract

The proposals to include a menstruation-related mood disorder in the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R), and DSM-IV led to intense public and behind-the-scenes controversy. Although the controversies surrounding the DSM-5 revision were greater in number than the controversies of the earlier revisions, the DSM-5 proposal to include a menstruation-related mood disorder was not among them. Premenstrual dysphoric disorder was made an official disorder in the DSM-5 with no significant protest. To understand the factors that led to this change, we interviewed those psychiatrists and psychologists who were most involved in the DSM-IV revision. On the basis of these interviews, we offer a list of empirical and nonempirical considerations that led to the DSM-IV compromise and explore how key alterations in these considerations led to a different outcome for the DSM-5.

Entities:  

Mesh:

Year:  2014        PMID: 24647220     DOI: 10.1097/NMD.0000000000000128

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  4 in total

1.  Klerman's "credo" reconsidered: neo-Kraepelinianism, Spitzer's views, and what we can learn from the past.

Authors:  Jerome C Wakefield
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

Review 2.  Psychopharmacotherapy of Premenstrual Dysphoric Disorder-New Vistas.

Authors:  Ahmed Naguy; Adel El-Sheshai; Sri Haricharan Thiguti; Bibi Alamiri
Journal:  Psychopharmacol Bull       Date:  2022-06-27

3.  The nature of psychiatric disorders.

Authors:  Kenneth S Kendler
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

4.  Prevalence of premenstrual syndrome and its association with psychosocial and lifestyle variables: a cross-sectional study from Palestine.

Authors:  Reem Abu Alwafa; Manal Badrasawi; Raheeq Haj Hamad
Journal:  BMC Womens Health       Date:  2021-06-05       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.